| Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders LP Aiello, RL Avery, PG Arrigg, BA Keyt, HD Jampel, ST Shah, ... New England Journal of Medicine 331 (22), 1480-1487, 1994 | 4791 | 1994 |
| The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. JE Park, GA Keller, N Ferrara Molecular biology of the cell 4 (12), 1317-1326, 1993 | 1530 | 1993 |
| Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. JE Park, HH Chen, J Winer, KA Houck, N Ferrara Journal of Biological Chemistry 269 (41), 25646-25654, 1994 | 1435 | 1994 |
| A specific antidote for dabigatran: functional and structural characterization F Schiele, J van Ryn, K Canada, C Newsome, E Sepulveda, J Park, H Nar, ... Blood, The Journal of the American Society of Hematology 121 (18), 3554-3562, 2013 | 747 | 2013 |
| Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts JE Park, MC Lenter, RN Zimmermann, P Garin-Chesa, LJ Old, WJ Rettig Journal of Biological Chemistry 274 (51), 36505-36512, 1999 | 632 | 1999 |
| Brefeldin A causes a microtubule-mediated fusion of the trans-Golgi network and early endosomes SA Wood, JE Park, WJ Brown Cell 67 (3), 591-600, 1991 | 471 | 1991 |
| Inhibition of PDGF, VEGF and FGF signalling attenuates fibrosis NI Chaudhary, GJ Roth, F Hilberg, J Müller-Quernheim, A Prasse, ... European Respiratory Journal 29 (5), 976-985, 2007 | 427 | 2007 |
| Pharmacologic differentiation of inflammation and fibrosis in the rat bleomycin model NI Chaudhary, A Schnapp, JE Park American journal of respiratory and critical care medicine 173 (7), 769-776, 2006 | 409 | 2006 |
| Fibroblast activation protein: a cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at the tissue remodelling interface in human cirrhosis MT Levy, GW McCaughan, CA Abbott, JE Park, AM Cunningham, E Müller, ... Hepatology 29 (6), 1768-1778, 1999 | 347 | 1999 |
| Fibroblast activation protein: differential expression and serine protease activity in reactive stromal fibroblasts of melanocytic skin tumors MA Huber, RD Schubert, RU Peter, N Kraut, JE Park, WJ Rettig, ... Journal of investigative Dermatology 120 (2), 182-188, 2003 | 193 | 2003 |
| β-Catenin and TGFβ signalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial to mesenchymal transition A Eger, A Stockinger, J Park, E Langkopf, M Mikula, J Gotzmann, ... Oncogene 23 (15), 2672-2680, 2004 | 192 | 2004 |
| Molecular cloning and characterization of endosialin, a C-type lectin-like cell surface receptor of tumor endothelium S Christian, H Ahorn, A Koehler, F Eisenhaber, HP Rodi, P Garin-Chesa, ... Journal of Biological Chemistry 276 (10), 7408-7414, 2001 | 178 | 2001 |
| Acetylcholine-induced proliferation of fibroblasts and myofibroblasts in vitro is inhibited by tiotropium bromide MP Pieper, NI Chaudhary, JE Park Life sciences 80 (24-25), 2270-2273, 2007 | 139 | 2007 |
| Targeted disruption of mouse fibroblast activation protein J Niedermeyer, M Kriz, F Hilberg, P Garin-Chesa, U Bamberger, ... Molecular and Cellular Biology, 2000 | 137 | 2000 |
| Dabigatran anticoagulant activity is neutralized by an antibody selective to dabigatran in in vitro and in vivo models J Van Ryn, T Litzenburger, A Waterman, K Canada, N Hauel, C Sarko, ... Journal of the American College of Cardiology 57 (14S), E1130-E1130, 2011 | 95 | 2011 |
| Mouse fibroblast‐activation protein: Conserved Fap gene organization and biochemical function as a serine protease J Niedermeyer, B Enenkel, JE Park, M Lenter, WJ Rettig, K Damm, ... European journal of biochemistry 254 (3), 650-654, 1998 | 95 | 1998 |
| FAPalpha-specific antibody with improved producibility JE Park, P Garin-chesa, U Bamberger, O Leger, J Saldanha, WJ Rettig EP Patent 0,953,639, 1999 | 92* | 1999 |
| Molecular cloning and characterization of EndoGlyx-1, an EMILIN-like multisubunit glycoprotein of vascular endothelium S Christian, H Ahorn, M Novatchkova, P Garin-Chesa, JE Park, G Weber, ... Journal of Biological Chemistry 276 (51), 48588-48595, 2001 | 76 | 2001 |
| Species-Crossreactive scFv Against the Tumor Stroma Marker “Fibroblast Activation Protein” Selected by Phage Display From an Immunized FAP−/− Knock-Out … B Brocks, P Garin-Chesa, E Behrle, JE Park, WJ Rettig, K Pfizenmaier, ... Molecular medicine 7, 461-469, 2001 | 73 | 2001 |
| Expression and targeting of human fibroblast activation protein in a human skin/severe combined immunodeficient mouse breast cancer xenograft model K Tahtis, FT Lee, JM Wheatley, P Garin-Chesa, JE Park, FE Smyth, ... Molecular cancer therapeutics 2 (8), 729-737, 2003 | 48 | 2003 |
